Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-05

FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approves a generic Triamcinolone Acetonide topical product under an Original Application (ANDA) for Padagis Israel Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

ORIG AP for TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)